Category
Description
It consists of human islets (n=10, subdivided into 2 batches) treated with IFNγ + IL-1β for 24 h and submitted to proteomics, lipidomics and metabolomics in the same samples (Table 1)
Data contributors:
Ernesto S. Nakayasu, Jennifer Kyle, Young-Mo Kim, Soumyadeep Sarkar & Thomas O. Metz: Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, 99354, USA.
Farooq Syed: Center for Diabetes and Metabolic Diseases, Indiana University School of Medicine, Indianapolis, IN, USA & Department of Diabetes Immunology, Beckman Research Institute, City of Hope, Duarte, CA, USA.
Rahavendra Mirmira: Kovler Diabetes Center and Department of Medicine, The University of Chicago, Chicago, IL, 60637, USA.
Data repositories:
Proteomics: PXD009131
Lipidomics: MSV000086174
Metabolomics: https://osf.io/nskdc
Publications: PMID 31928885, PMID 38383396 & 10.1101/2024.09.16.24313433